Abstract
Coronaviruses have been thrust into the spotlight by the recurring novel human coronavirus infections following the 2003 SARS pandemic. In the years since the initial SARS outbreak, the arsenal to fight this virus family has been significantly increased by the rapid growth of coronavirus research. Among the potential viral drug targets, coronavirus 3C like proteases (3Cl) have emerged as the most popular drug target. A number of patented inhibitors with promising clinical potential have been developed via different methods of drug discovery, including virtual screening, natural product isolation and structure assisted rational drug design. This review serves as a summary of the progress in both the method of drug discovery and the related inhibitors against the coronavirus 3Cl protease.
Keywords: Antiviral, 3C like proteases, coronavirus, inhibitor, main protease, natural product, rational drug design, virtual screening.
Recent Patents on Anti-Infective Drug Discovery
Title:Recent Developments on Coronavirus Main Protease/3C Like Protease Inhibitors
Volume: 8 Issue: 2
Author(s): Qi Zhao, Erin Weber and Haitao Yang
Affiliation:
Keywords: Antiviral, 3C like proteases, coronavirus, inhibitor, main protease, natural product, rational drug design, virtual screening.
Abstract: Coronaviruses have been thrust into the spotlight by the recurring novel human coronavirus infections following the 2003 SARS pandemic. In the years since the initial SARS outbreak, the arsenal to fight this virus family has been significantly increased by the rapid growth of coronavirus research. Among the potential viral drug targets, coronavirus 3C like proteases (3Cl) have emerged as the most popular drug target. A number of patented inhibitors with promising clinical potential have been developed via different methods of drug discovery, including virtual screening, natural product isolation and structure assisted rational drug design. This review serves as a summary of the progress in both the method of drug discovery and the related inhibitors against the coronavirus 3Cl protease.
Export Options
About this article
Cite this article as:
Zhao Qi, Weber Erin and Yang Haitao, Recent Developments on Coronavirus Main Protease/3C Like Protease Inhibitors, Recent Patents on Anti-Infective Drug Discovery 2013; 8 (2) . https://dx.doi.org/10.2174/1574891X113089990017
DOI https://dx.doi.org/10.2174/1574891X113089990017 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Editorial (Thematic Issue: Enzymatic Studies in Medicinal Chemistry of Neglected Diseases)
Current Protein & Peptide Science Recent Advances in PI3 Kinase Inhibitors: Anticancer Activities and Structure-Activity Relationships
Mini-Reviews in Medicinal Chemistry Human Opiorphin an Endogenous Inhibitor of Enkephalin-Inactivating Ectopeptidases that Displays Antinociception: A Review
Current Bioactive Compounds Can Mandated BCG Vaccine Promote herd Immunity against Novel Coronavirus? A Potential Solution at Hand to Tackle Covid-19 Pandemic
Current Immunology Reviews (Discontinued) Probability Issues in Molecular Design: Predictive and Modeling Ability in 3D-QSAR Schemes
Combinatorial Chemistry & High Throughput Screening Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools
Current Neuropharmacology Meet Our Editorial Board Member
Current HIV Research Lipid-Based Nanocarriers for CNS-Targeted Drug Delivery
Recent Patents on CNS Drug Discovery (Discontinued) Design and Efficient Synthesis of Novel 4,5-Dimethylthiazole-Hydrazone Derivatives and their Anticancer Activity
Letters in Drug Design & Discovery A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P)
Recent Patents on Inflammation & Allergy Drug Discovery Advances in the Development of Bradykinin Receptor Ligands
Current Topics in Medicinal Chemistry The Biology of Persistent Infection: Inflammation and Demyelination Following Murine Coronavirus Infection of the Central Nervous System
Current Immunology Reviews (Discontinued) Sulfur-Containing Compounds in Protecting Against Oxidant-Mediated Lung Diseases
Current Medicinal Chemistry Lessons from Animal Culling during Human Pandemics: Is Vaccination a Viable Option for Animals?
Current Pediatric Reviews Surfactant Protein A - From Genes to Human Lung Diseases
Current Medicinal Chemistry Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases
Current Topics in Medicinal Chemistry Tripentones: A Promising Series of Potent Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry 1,2,4-Oxadiazoles Identified by Virtual Screening and their Non-Covalent Inhibition of the Human 20S Proteasome
Current Medicinal Chemistry Mechanism of Conjugated Imine and Iminium Species, including Marine Alkaloids: Electron Transfer, Reactive Oxygen Species, Therapeutics and Toxicity
Current Bioactive Compounds Lactones: Generic Inhibitors of Enzymes?
Mini-Reviews in Medicinal Chemistry